Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-25 @ 4:03 AM
NCT ID:
NCT04198402
Eligibility Criteria:
Inclusion Criteria:
* 18 years old or older
* naive patient with digestive neuroendocrine tumor (pancreas (cytology or histology per endoscopy or on surgical specimen) or small intestine), secreting or not, initiating a extended release Lanreotide treatment
* registered with a social security scheme
Exclusion Criteria:
* medical contraindication to somatostatine analogs use
* history of extended release somatostatine analogs treatment
* antibiotic use or colonoscopic purge in the last 3 weeks preceding fecal sample
* pregnant or breastfeeding women
* person requiring tutorship, guardianship, or person legally protected
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04198402
Study Brief:
Protocol Section:
NCT04198402